333 related articles for article (PubMed ID: 34834316)
21. miRNA nanotherapeutics for cancer.
Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
[TBL] [Abstract][Full Text] [Related]
22. miRNA cassettes in viral vectors: problems and solutions.
Liu YP; Berkhout B
Biochim Biophys Acta; 2011; 1809(11-12):732-45. PubMed ID: 21679781
[TBL] [Abstract][Full Text] [Related]
23. Micro-RNA (miRNA): A Biomarker to Identify Novel Compounds in Drug Discovery and Delivery for Cancer Therapy.
Paramasivam G
Curr Drug Discov Technol; 2021; 18(6):e130921188092. PubMed ID: 33208078
[TBL] [Abstract][Full Text] [Related]
24. Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics.
Cuciniello R; Filosa S; Crispi S
J Exp Clin Cancer Res; 2021 Dec; 40(1):383. PubMed ID: 34863235
[TBL] [Abstract][Full Text] [Related]
25. Lipid nanocarriers for microRNA delivery.
Scheideler M; Vidakovic I; Prassl R
Chem Phys Lipids; 2020 Jan; 226():104837. PubMed ID: 31689410
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs and Their Big Therapeutic Impacts: Delivery Strategies for Cancer Intervention.
Holjencin C; Jakymiw A
Cells; 2022 Jul; 11(15):. PubMed ID: 35954176
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA: Promising Roles in Cancer Therapy.
Hashemi A; Gorji-Bahri G
Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
[TBL] [Abstract][Full Text] [Related]
28. MiRNA-based Therapeutics for Lung Cancer.
Wu M; Wang G; Tian W; Deng Y; Xu Y
Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413
[TBL] [Abstract][Full Text] [Related]
29. microRNAs: New-Age Panacea in Cancer Therapeutics.
Sarkar N; Kumar A
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):52-56. PubMed ID: 33994728
[TBL] [Abstract][Full Text] [Related]
30. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T; Rácz Z; Hamar P
Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
[TBL] [Abstract][Full Text] [Related]
31. Exploiting the therapeutic potential of microRNAs in viral diseases: expectations and limitations.
Hemida MG; Ye X; Thair S; Yang D
Mol Diagn Ther; 2010 Oct; 14(5):271-82. PubMed ID: 21053993
[TBL] [Abstract][Full Text] [Related]
32. Scaffold-Based microRNA Therapies in Regenerative Medicine and Cancer.
Curtin CM; Castaño IM; O'Brien FJ
Adv Healthc Mater; 2018 Jan; 7(1):. PubMed ID: 29068566
[TBL] [Abstract][Full Text] [Related]
33. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases.
Pandey M; Ojha D; Bansal S; Rode AB; Chawla G
Mol Aspects Med; 2021 Oct; 81():101003. PubMed ID: 34332771
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in the Host Response to Viral Infections of Veterinary Importance.
Samir M; Vaas LA; Pessler F
Front Vet Sci; 2016; 3():86. PubMed ID: 27800484
[TBL] [Abstract][Full Text] [Related]
35. Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models.
Yanai K; Kaneko S; Ishii H; Aomatsu A; Morishita Y
J Vis Exp; 2022 May; (183):. PubMed ID: 35635449
[TBL] [Abstract][Full Text] [Related]
36. Small non-coding RNAs as novel therapeutics.
Rossbach M
Curr Mol Med; 2010 Jun; 10(4):361-8. PubMed ID: 20455856
[TBL] [Abstract][Full Text] [Related]
37. Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.
Ahmadzada T; Reid G; McKenzie DR
Biophys Rev; 2018 Feb; 10(1):69-86. PubMed ID: 29327101
[TBL] [Abstract][Full Text] [Related]
38. miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy.
Savenkova DA; Makarova AA; Shalik IK; Yudkin DV
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499289
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.
Wang H; Qin L; Zhang X; Guan J; Mao S
J Control Release; 2022 Dec; 352():970-993. PubMed ID: 36372386
[TBL] [Abstract][Full Text] [Related]
40. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
He W; Turkeshi A; Li X; Zhang H
Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
